US FDA approves Cysview™ (hexaminolevulinate HCl) for detection of bladder cancer

被引：0

|

作者：

不详

机构：

来源：

FUTURE ONCOLOGY | 2010年 / 6卷 / 07期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：1070 / 1070

页数：1

相关论文

共 50 条

[41] The role of hexaminolevulinate fluorescence cystoscopy in bladder cancer
Witjes, J. Alfred
Douglass, Jude
NATURE CLINICAL PRACTICE UROLOGY, 2007, 4 (10): : 542 - 549
[42] US FDA approves new treatment for HER2-positive breast cancer
Galukande, Natasha
PHARMACOGENOMICS, 2013, 14 (06) : 600 - 600
[43] The role of hexaminolevulinate fluorescence cystoscopy in bladder cancer
J Alfred Witjes
Jude Douglass
Nature Clinical Practice Urology, 2007, 4 : 542 - 549
[44] FLUORESCENCE CYSTOSCOPY WITH HEXAMINOLEVULINATE IN BLADDER CANCER: OUR EXPERIENCE
Massimiliano, P.
Cracco, C.
Scoffone, C.
Cossu, M.
Grande, S.
Scarpa, R.
JOURNAL OF ENDOUROLOGY, 2009, 23 : A66 - A66
[45] FDA - Approved biomarkers for detection and monitoring of bladder cancer
Wojcik, EM
JOURNAL OF HISTOTECHNOLOGY, 2000, 23 (02) : 162 - 162
[46] FDA approves PARP inhibitor for ovarian cancer
Nature Biotechnology, 2017, 35 : 398 - 398
[47] FDA Approves Afatinib for Advanced Lung Cancer
不详
ONCOLOGY-NEW YORK, 2013, 27 (08): : 813 - 814
[48] FDA APPROVES TEST FOR PROSTATIC-CANCER
CHARATAN, FB
BRITISH MEDICAL JOURNAL, 1994, 309 (6955): : 628 - 629
[49] FDA Approves Several Diagnostic Tests for Cancer
Printz, Carrie
CANCER, 2016, 122 (16) : 2451 - 2452
[50] FDA approves first therapeutic MAB for cancer
不详
BIOTECHNOLOGY LAW REPORT, 1998, 17 (01): : 5 - 6

← 1 2 3 4 5 →